| Company | Designation | Period |
|---|---|---|
| Uth Healthcare | Member Board of Directors | Nov 2015 – Aug 2017 |
| Societe Generale | Assistant Vice President | Mar 2007 – Mar 2008 |
| GlaxoSmithKline | Manager - Business Development | Jun 2010 – Jun 2012 |
| Emcure Pharmaceuticals Limited | Director - Business Development | Jul 2012 – Oct 2014 |
| NRI Business, Citibank | Relationship Manager | Jan 2006 – Jan 2007 |
| Citigroup | Relationship Manager | Jan 2003 – Jan 2007 |
| Diagnovet Analytics India | Founder | Dec 2019 – Mar 2021 |
| Vivaldis Health and Foods Private Limited | Founder CEO | Nov 2014 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Vivaldis Animal Health corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Kunal Khanna's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Vivaldis Animal Health's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)